Biomedical Engineering Reference
In-Depth Information
seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta sub-
unit-mediated modulation of sodium channel function. Neuroscience 148:164-174
24. Patino GA, Claes LR, Lopez-Santiago LF, Slat EA, Dondeti RS, Chen C, O'Malley HA,
Gray CB, Miyazaki H, Nukina N, Oyama F, De Jonghe P, Isom LL (2009) A functional null
mutation of SCN1B in a patient with Dravet syndrome. J Neurosci 29:10764-10778
25. Holland KD, Kearney JA, Glauser TA, Buck G, Keddache M, Blankston JR, Glaaser IW,
Kass RS, Meisler MH (2008) Mutation of sodium channel
SCN3A
in a patient with crypto-
genic pediatric partial epilepsy. Neurosci Lett 433:65-70
26. Singh NA, Pappas C, Dahle EJ, Claes LR, Pruess TH, De Jonghe P, Thompson J, Dixon M,
Gurnett C, Peiffer A, White HS, Filloux F, Leppert MF (2009) A role of
SCN9A
in human
epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS
Genet 5:e1000649
27. Tang B, Dutt K, Papale L, Rusconi R, Shankar A, Hunter J, Tufik S, Yu FH, Catterall WA,
Mantegazza M, Goldin AL, Escayg A (2009) A BAC transgenic mouse model reveals neuron
subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+)
mutation. Neurobiol Dis 35:91-102
28. Fujiwara T, Sugawara T, Mazaki-Miyazaki E, Takahashi Y, Fukushima K, Watanabe M,
Hara K, Morikawa T, Yagi K, Yamakawa K, Inoue Y (2003) Mutations of sodium channel
alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized
tonic-clonic seizures. Brain 126:531-546
29. Rhodes TH, Lossin C, Vanoye CG, Wang DW, George AL Jr (2004) Noninactivating
voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc Natl Acad
Sci USA 101:11147-11152
30. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, Spain WJ,
McKnight GS, Scheuer T, Catterall WA (2006) Reduced sodium current in GABAergic
interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci
9:1142-1149
31. Ragsdale DS (2008) How do mutant Nav1.1 sodium channels cause epilepsy? Brain Res Rev
58:149-159
32. Catterall WA, Goldin AL, Waxman SG (2005) International Union of Pharmacology. XLVII.
Nomenclature and structure-function relationships of voltage-gated sodium channels.
Pharmacol Rev 57:397-409
33. Misra SN, Khalig KM, George AL Jr (2008) Impaired NaV1.2 function and reduced cell
surface
expression
in
benign
familial
neonatal-infantile
seizures. Epilepsia
49:1535-1545
34. Wallace RH, Wang DW, Singh R, Scheffer IE, George AL Jr, Phillips HA, Saar K, Reis A,
Johnson EW, Sutherland GR, Berkovic SF, Mulley JC (1998) Febrile seizures and
generalized epilepsy associated with a mutation in the Na
+
-channel beta1 subunit gene
SCN1B
. Nat Genet 19:366-370
35. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG (2007) From genes to pain: NaV1.7 and
human pain disorders. Trends Neurosci 30:555-563
36. Lampert A, O'Reilly AO, Reeh P, Leffler A (2010) Sodium channelopathies and pain.
Pflugers Arch Eur J Physiol 460:249-263
37. Cregg R, Momin A, Rugiero F, Wood JN, Zhao J (2010) Pain channelopathies. J Physiol
588:1897-1904
38. Rice AS, Hill RG (2006) New treatments for neuropathic pain. Annu Rev Med 57:535-551
39. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA,
Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede R-D,
Turk DC, Wallace MS (2007) Pharmacologic management of neuropathic pain: evidence-
based recommendations. Pain 132:237-251
40. Waxman SG, Kocsis JD, Black JA (1994) Type III sodium channel mRNA is expressed in
embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J
Neurophysiol 72:466-470
